|本期目录/Table of Contents|

[1]曾庆波,宋景春,钟林翠,等.严重创伤与脓毒症患者凝血功能紊乱的比较研究[J].医学研究与战创伤救治(原医学研究生学报),2020,22(4):367-371.[doi:10.3969/j.issn.1672-271X.2020.04.007]
　ZENG Qing-bo,SONG Jing-chun,ZHONG Lin-cui,et al.Comparation of coagulation dysfunction between severe trauma and sepsis patients[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(4):367-371.[doi:10.3969/j.issn.1672-271X.2020.04.007]
点击复制

严重创伤与脓毒症患者凝血功能紊乱的比较研究()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第22卷
期数:
2020年4期
页码:
367-371
栏目:
临床研究
出版日期:
2020-07-20

文章信息/Info

Title:
Comparation of coagulation dysfunction between severe trauma and sepsis patients
作者:
曾庆波; 宋景春; 钟林翠; 林青伟; 邓星平; 宋晓敏
作者单位：330002 南昌，解放军联勤保障部队第九○八医院重症医学科（曾庆波、宋景春、钟林翠、林青伟、邓星平、宋晓敏）
Author(s):
ZENG Qing-bo;  SONG Jing-chun;  ZHONG Lin-cui;  LIN Qing-wei;  DENG Xing-ping;  SONG Xiao-min
(Intensive Care Unit, the 908th Hospital of Chinese PLA Logistical Support Force,Nanchang 330002, Jiangxi, China)
关键词:
创伤; 脓毒症; 凝血; 分子标志物; 血栓弹力图
Keywords:
trauma;  sepsis;  coagulation;  molecular marker;  thromboelastography
分类号:
R55
DOI:
10.3969/j.issn.1672-271X.2020.04.007
文献标志码:
A
摘要:
目的应用血栓弹力图（TEG）和凝血分子标志物评估创伤与脓毒症患者凝血功能紊乱的特征。方法回顾性分析解放军联勤保障部队第九○八医院重症医学科2018年6月至2019年6月住院治疗的创伤患者49例（创伤组）与脓毒症患者79例（脓毒症组）入科时的基础资料，统计入院30 min内的血栓调节蛋白（TM）、凝血酶-抗凝血酶复合物（TAT）、纤溶酶-α2纤溶酶抑制物复合物（PIC）、组织纤溶酶原激活物/纤溶酶原激活物抑制剂-1复合物（tPAI-C）、血浆凝血酶原时间（PT）、活化部分凝血活酶时间（APTT）、纤维蛋白原（FIB）、凝血酶原时间（TT）、纤维蛋白降解产物（FDP）、D二聚体（DD）以及TEG指标，并进行统计学分析。结果与脓毒症组患者的TM[13.0（10.1，20.2）TU/mL]、TAT[9.4（5.6，21.1）ng/mL]、PIC[1.33（0.72，2.46）μg/mL]、FDP[13.2（6.9，27.3）μg/mL]、DD[3.7（2.0，7.7）μg/mL] 、FIB[2.8（2.1，3.8）g/L]和TEG的MA[57.9（50.6，64.5）mm]相比，创伤组患者的TAT[41.1（16.2，120）ng/mL]、PIC[4.12（1.06，9.09）μg/mL]、FDP[52.9（13.2，137.2）μg/mL]和DD[10.5（3.8，30.7）μg/mL]明显升高（P<0.05），TM [9.7（7.8，12.1）TU/mL]、FIB[1.5（1.0，2.2）g/L]和TEG的MA[47.5（38.7，55.3）mm]明显降低（P<0.05）。创伤患者的TAT、PIC与FDP和DD呈强相关（P<0.05）。结论严重创伤相关凝血紊乱主要表现为血小板功能障碍和纤溶功能亢进，脓毒症相关凝血紊乱主要表现为内皮细胞功能障碍，联合应用TM、TAT和PIC可区分创伤与脓毒症相关的凝血障碍。
Abstract:
ObjectiveTo evaluate the hematological differences between sepsis and trauma patients using the rotational thromboelastography (TEG) and plasma biomarkers.MethodsThis retrospective study includes all sepsis or severe trauma patients transported to our intensive care unit who underwent TEG and coagulation parameters from Jun 2018 to Jun 2019，including thrombin antithrombin complex(TAT), a2-plasmininhibitor-plasmin complex (PIC), soluble thrombomodulin (sTM), tissue plasminogen activator-inhibitor complex (tPAIC).All 128 patients (79 sepsis and 49 severe trauma) were included in primary analysis. All the demographics, clinical characteristics, laboratory data were statistically analyzed between sepsis and severe trauma patients.ResultsCompared with the TM[13.0（10.1，20.2）TU/mL]，TAT[9.4（5.6，21.1）ng/mL],PIC[1.33（0.72，2.46）μg/mL],FDP[13.2（6.9，27.3）μg/mL],DD[3.7（2.0，7.7）μg/mL], FIB[2.8（2.1，3.8）g/L] and MA[57.9（50.6，64.5）mm] of sepsis group, the TAT[41.1（16.2，120）ng/mL], PIC[4.12（1.06，9.09）μg/mL],FDP[52.9（13.2，137.2）μg/mL] and DD[10.5（3.8，30.7）μg/mL] of the trauma group was significantly higher（P<0.05）；TM [9.7（7.8，12.1）TU/mL]，the FIB[1.5（1.0，2.2）g/L] and MA[47.5（38.7，55.3）mm] became significantly lower (P<0.05).TAT and PIC were significantly associated with FDP or DD (P<0.05).ConclusionCoagulation disorder in severe trauma is mainly manifested as platelet dysfunction and hyperfibrinolysis. Sepsis-induced coagulopathy mainly manifested as endothelial cell dysfunction. The combination of TM, TAT andPIC can distinguish coagula-tion disorder of trauma from sepsis.

参考文献/References:

[1]江伟,杜斌.中国脓毒症流行病学现状[J]. 医学研究生学报,2019,32(1):5-8.
[2]Hayakawa M, Yamakawa K, Saito S,et al. Nationwide registry of sepsis patients in Japan focused on disseminated intravascular coagulation 2011-2013[J]. Sci Data,2018,11(5):180243.
[3]Harris T,Davenport R, Mak M, et al. The Evolving Science of Trauma Resuscitation[J]. Emerg Med Clin North Am,2018,36(1):85-106.
[4]Fleischmann C, Scherag A, Adhikari NK, et al. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitation[J]. Am J Respair Crit Care Med, 2016, 193(3):259-272.
[5]Papageorgiou C, Jourdi G, Adjambri E, et al. Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies[J]. Clin Appl Thromb Hemost,2018. doi: 10.1177/1076029618806424.
[6]Iba T，Nisio MD，Levy JH. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey[J]. BMJ Open，2017，9（7）. doi: 10.1136/bmjopen-2017-017046.
[7]Lancé MD. A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis[J]. Thromb J,2015，13:1. doi: 10.1186/1477-9560-13-1.
[8]Mei H, Jiang Y, Luo L, et al. Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study[J]. Thromb Res,2019，173:20-26.
[9]Minasyan H, Flachsbart F. Blood coagulation: a powerful bactericidal mechanism of human innate immunity[J]. Int Rev Immunol，2019,38(1):1-15.
[10]Levi M. Pathogenesis and diagnosis of disseminated intravascular coagulation[J]. Int J Lab Hematol，2018, 40 Suppl 1:15-20.
[11]Koami H, Sakamoto Y, Sakurai R, et al. The thromboelastometric discrepancy between septic and trauma induced disseminated intravascular coagulation diagnosed by the scoring system from the Japanese association for acute medicine[J]. Medicine，2016，95(31):e4514. doi: 10.1097/MD.0000000000004514.
[12]Kaukonen KM, Bailey M, Suzuki S, et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012[J]. JAMA，2014, 311(13):1308-1316.
[13]Spence RT, Scott JW, Haider A, et al. Comparative assessment of in-hospital trauma mortality at a South African trauma center and matched patients treated in the United States[J]. Surgery，2017,162(3):620-627.
[14]姚咏明,张艳敏.脓毒症发病机制最新认识[J]. 医学研究生学报,2017,30(7):678-683.
[15]Strong BL, Greene CR, Smith GS. Trauma Recidivism Predicts Long-term Mortality: Missed Opportunities for Prevention (Retrospective Cohort Study)[J]. Ann Surg，2017, 265(5):847-853.
[16]Aubron C, Reade MC, Fraser JF, et al. Efficacy and safety of fibrinogen concentrate in trauma patients-a systematic review[J]. J Crit Care,2014，29(3):471.
[17]Inaba K, Karamanos E, Lustenberger T, et al. Impact of fibrinogen levels on outcomes after acute injury in patients requiring a massive transfusion[J]. J Am Coll Surg，2013，216(2):290-297.
[18]Saes JL, Schols SEM, van Heerde WL, et al. Hemorrhagic disorders of fibrinolysis: a clinical review[J]. J Thromb Haemost，2018. doi: 10.1111/jth.14160.
[19]Sivula M, Pettila V, Niemi TT, et al. Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation[J]. Blood Coagul Fibrinolysis，2009，20(6):419-426.
[20]Ogura H, Gando S, Iba T, et al. SIRS-associated coagulopathy and organ dysfunction in critically ill patients with thrombocytopenia[J]. Shock,2007,28(4):411-417.
[21]Wang Y, Ouyang Y, Liu B, et al. Platelet activation and antiplatelet therapy in sepsis: A narrative review[J]. Thromb Res，2018, 166:28-36.
[22]Ogawa Y，Yamakawa K，Ogura H，et al．Recombinant human soluble thrombomodulin improves mortality and respiratory dysfunction in patients with severe sepsis［J］.J Trauma Acute Care Surg，2012，72( 5) : 1150-1157.
[23]Kato T，Sakai T，Kato M，et al. Recombinant human soluble thrombomodulin administration improves sepsis-induced disseminated intravascular coagulation and mortality: a retrospective cohort study[J]．Thromb J，2013，11(1) : 3. doi: 10.1186/1477-9560-11-3.
[24]Gao M, Fan F, Li D, et al. Tumor acidity-activatable TAT targeted nanomedicine for enlarged fluorescence/magnetic resonance imaging-guided photodynamic therapy[J]. Biomaterials, 2017, 133:165-175.
[25]Yoo SH, Venn E, Sullivan LA, et al. Thromboelastographic evidence of inhibition of fibrinolysis after ε-aminocaproic acid administration in a dog with suspected acute traumatic coagulopathy[J]. J Vet Emerg Crit Care (San Antonio)，2016，26(5):737-742.

相似文献/References:

[1]孙宝迪,刘红梅综述,聂时南审校.限制性液体复苏在创伤失血性休克中的进展[J].医学研究与战创伤救治(原医学研究生学报),2012,14(02):145.
[2]徐东升,王发祥,卢 峰,等.乌司他汀治疗创伤性失血性休克的疗效观察[J].医学研究与战创伤救治(原医学研究生学报),2011,13(05):448.
[3]何志安,赖江琼,刘国安,等.B超在外伤性腹膜后血肿诊治中的价值[J].医学研究与战创伤救治(原医学研究生学报),2010,12(02):159.
[4]宋启哲,董茂生,董晓敏,等.SWOT分析法在疗养院创伤康复专科中心建设中的应用[J].医学研究与战创伤救治(原医学研究生学报),2009,11(02):171.
[5]张 丽,侯毅翰,张民伟,等.降钙素原在血流感染中的临床应用分析[J].医学研究与战创伤救治(原医学研究生学报),2013,15(06):603.[doi:10.3969/j.issn.1672-271X.2013.06.016]
　ZHANG Li,HOU Yi-han,ZHANG Min-wei,et al.Cost-effective analysis of procalcitonin in the diagnosis of bloodstream infection[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2013,15(4):603.[doi:10.3969/j.issn.1672-271X.2013.06.016]
[6]黄凤楼,刁孟元,钱海飞,等.降钙素原及内毒素对腹腔感染脓毒症患者预后的评估[J].医学研究与战创伤救治(原医学研究生学报),2014,16(02):147.[doi:10.3969/j.issn.1672-271X.2014.02.011]
　HUANG Feng-lou,DIAO Meng-yuan,QIAN Hai-fei,et al.Prognostic value of procalcitonin and endotoxin concentrations for intra-abdominal sepsis[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2014,16(4):147.[doi:10.3969/j.issn.1672-271X.2014.02.011]
[7]刘 瑜,方 放,黄 方.糖皮质激素受体基因多态性与脓毒症临床转归的相关性研究[J].医学研究与战创伤救治(原医学研究生学报),2015,17(06):575.[doi:10.3969/j.issn.1672-271X.2015.06.005]
　LIU Yu,FANG Fang,HUANG Fang..Association of polymorphisms in glucocorticoid receptor with outcome of sepsis in a Chinese Han population[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2015,17(4):575.[doi:10.3969/j.issn.1672-271X.2015.06.005]
[8]陈松林,易云峰,田素科,等.单孔电视胸腔镜在单纯性创伤性膈疝中的治疗分析[J].医学研究与战创伤救治(原医学研究生学报),2017,19(02):117.[doi:10.3969/j.issn.1672-271X.2017.02.002]
　CHEN Song-lin,YI Yun-feng,TIAN Su-ke,et al.The treatment of single-portthoracoscopic in simple traumatic diaphragmatic hernia[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2017,19(4):117.[doi:10.3969/j.issn.1672-271X.2017.02.002]
[9]田素科,易云峰,陈松林,等.创伤性血胸合并胸椎爆裂骨折的救治体会[J].医学研究与战创伤救治(原医学研究生学报),2017,19(04):341.[doi:10.3969/j.issn.1672-271X.2017.04.002]
　TIAN Su-ke,YI Yun-feng,CHEN Song-lin,et al.The treatment experiences of the traumatic hemothorax plus burst fracture of thoracic spine[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2017,19(4):341.[doi:10.3969/j.issn.1672-271X.2017.04.002]
[10]郭剑,雷洁洁,章柏平,等.脓毒症患者连续性肾替代治疗时机选择及预后比较[J].医学研究与战创伤救治(原医学研究生学报),2018,20(01):37.[doi:10.3969/j.issn.1672-271X.2018.01.008]
　GUO Jian,LEI Jie-jie,ZHANG Bo-ping,et al.Comparison of timing and prognosis of continuous renal replacement therapy in patients with sepsis[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(4):37.[doi:10.3969/j.issn.1672-271X.2018.01.008]
[11]陈慧敏,王立群,黄利民,等.降钙素原变化率对创伤后脓毒症患者抗生素合理使用的指导价值[J].医学研究与战创伤救治(原医学研究生学报),2020,22(4):408.[doi:10.3969/j.issn.1672-271X.2020.04.016]

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2020-07-13